1Name of Instrument#
(1)This instrument is the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Determination 2017.
(2)This instrument may also be cited as PB 81 of 2017.
5Definitions#
In this Determination:
pharmaceutical item has the meaning given by section 84AB of the Act.
Note: Terms used in this Determination have the same meaning as in the Act – see section 13 of the Legislation Act 2003. These terms include:
• listed drug
• form
• manner of administration
6Exempt items#
The pharmaceutical items identified in the Schedule are exempt from statutory price reductions and price disclosure requirements under Division 3A and 3B of Part VII of the Act.
Schedule
| Listed Drug | Form (strength, type, size, etc.) | Manner of administration |
|---|---|---|
| Amisulpride | Oral solution 100 mg per mL, 60 mL | Oral |
| Amoxicillin | Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL | Oral |
| Azithromycin | Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15mL | Oral |
| Atenolol | Oral solution 50 mg in 10 mL, 300 mL | Oral |
| Brivaracetam | Oral solution 10 mg per mL, 300 mL | Oral |
| Captopril | Oral solution 5 mg per mL, 95 mL | Oral |
| Carbamazepine | Oral suspension 100 mg per 5 mL, 300 mL | Oral |
| Ciclosporin | Oral liquid 100 mg per mL, 50 mL | Oral |
| Ciclosporin | Capsule 10 mg | Oral |
| Ciclosporin | Solution concentrate for I.V. infusion 50 mg in 1 mL | Injection |
| Ciprofloxacin | Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the ear |
| Clarithromycin | Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral |
| Clonazepam | Oral liquid 2.5 mg per mL, 10 mL | Oral |
| Clonazepam | Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection |
| Diazepam | Oral liquid 10 mg per 10 mL, 100 mL | Oral |
| Digoxin | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral |
| Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral |
| Ethosuximide | Oral solution 250 mg per 5 mL, 200 mL | Oral |
| Fluconazole | Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral |
| Furosemide | Oral solution 10 mg per mL, 30 mL | Oral |
| Glyceryl Trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
| Indometacin | Suppository 100 mg | Rectal |
| Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL | Oral |
| Methadone | Injection containing methadone hydrochloride 10 mg in 1 mL | Injection |
| Metronidazole | Suppositories 500 mg, 10 | Rectal |
| Metronidazole | Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral |
| Nevirapine | Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL | Oral |
| Oxybutynin | Transdermal patches 36 mg, 8 | Transdermal |
| Oxycodone | Oral solution containing oxycodone hydrochloride 1 mg per mL, 1 mL | Oral |
| Pantoprazole | Sachet containing granules 40 mg (as sodium sesquihydrate) | Oral |
| Paracetamol | Oral liquid 240 mg per 5 mL, 200 mL | Oral |
| Paracetamol | Suppository 500 mg | Rectal |
| Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | Injection |
| Riluzole | Oral suspension 50 mg per 10 mL, 300 mL | Oral |
| Salbutamol | Oral solution 2 mg (as sulfate) per 5 mL, 150 mL | Oral |
| Salbutamol | Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) | Inhalation by mouth |
| Terbinafine | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | Application |
| Tofacitinib | Oral solution 1 mg per mL, 240 mL | Oral |
| Tramadol | Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL | Oral |
| Valganciclovir | Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL | Oral |
| Valproic Acid | Tablet, crushable, containing sodium valproate 100 mg | Oral |
| Valproic Acid | Oral liquid containing sodium valproate 200 mg per 5mL, 300 mL | Oral |
| Valproic Acid | Oral solution containing sodium valproate 200 mg per 5mL, 300 mL | Oral |
| Voriconazole | Powder for oral suspension 40 mg per mL, 70 mL | Oral |
Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.